CV Sciences, Inc. (OTCMKTS:CVSI) Short Interest Update

CV Sciences, Inc. (OTCMKTS:CVSIGet Free Report) saw a significant drop in short interest in April. As of April 30th, there was short interest totaling 15,330 shares, a drop of 81.3% from the April 15th total of 82,061 shares. Based on an average daily volume of 2,095,890 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the company’s stock are short sold.

CV Sciences Price Performance

CV Sciences stock traded up $0.00 during trading on Tuesday, hitting $0.03. 9,493 shares of the company were exchanged, compared to its average volume of 1,096,998. The business’s 50 day moving average is $0.04 and its 200 day moving average is $0.04. CV Sciences has a 52 week low of $0.02 and a 52 week high of $0.10. The company has a current ratio of 1.03, a quick ratio of 0.21 and a debt-to-equity ratio of 0.26.

CV Sciences Company Profile

(Get Free Report)

CV Sciences, Inc is a developer, manufacturer and marketer of hemp-derived products, with a focus on cannabidiol (CBD) formulations for both consumer and industrial applications. The company’s consumer segment offers a range of dietary supplements, topical creams, personal care items and pet products under its flagship PlusCBD™ Oil brand, while its industrial segment provides hemp-derived ingredients for use in wellness, pharmaceutical and cosmetic formulations.

Headquartered in San Diego, California, CV Sciences operates a manufacturing facility in El Cajon that oversees cultivation partnerships, extraction, refinement and product formulation.

Read More

Receive News & Ratings for CV Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CV Sciences and related companies with MarketBeat.com's FREE daily email newsletter.